Skip to content
GenoLensGenoLens

P3H1

Chr 1p34.2

prolyl 3-hydroxylase 1

Aliases:
GROS1, LEPRECAN, MGC117314
MANE:
ENST00000296388.10

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Osteogenesis imperfecta

    BIALLELIC, autosomal or pseudoautosomal
  • Skeletal dysplasia

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • osteogenesis imperfecta type 8

    0.75
  • osteogenesis imperfecta

    0.63
  • osteogenesis imperfecta type 3

    0.53
  • osteogenesis imperfecta, recessive

    0.46
  • osteogenesis imperfecta type 2

    0.37
  • skeletal dysplasia

    0.37
  • hereditary disease

    0.19
  • mixed connective tissue disease

    0.17
  • long QT syndrome 12

    0.12
  • neoplasm

    0.09

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Prolyl 3-hydroxylase 1

Has prolyl 3-hydroxylase activity and catalyzes the post-translational formation of 3-hydroxyproline in -Xaa-Pro-Gly- sequences in pro-collagen chains, a critical step for the formation of mature collagen trimers (PubMed:39245686). May be involved in the secretory pathway of cells. Has growth suppressive activity in fibroblasts

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.